Asia-Pacific Americas Africa Europe Middle East

BIOCON BIOSPHERE LIMITED

Company Profile:

Company Profile: Biocon Biologics Limited

Biocon Biologics Limited is a leading Indian biopharmaceutical company headquartered in Bangalore, India. It is a subsidiary of Biocon Limited, focusing on the research, development, manufacturing, and commercialization of high-quality, affordable biosimilars and other biopharmaceutical products. The company aims to provide global access to advanced biologics for conditions such as diabetes, oncology, immunology, and ophthalmology. Biocon Biologics has a robust pipeline of biosimilar products and operates state-of-the-art manufacturing facilities, adhering to global regulatory standards. Its mission is to make a significant impact on global healthcare by making innovative biologics accessible and affordable worldwide.

Nature of Business: Manufacturer (Factory)

Enterprise Products

Here are some of the products that Biocon Biologics (formerly Biocon Biosphere Limited) manufactures or markets:

* **Biosimilars:** Insulin Glargine, Insulin Aspart, Trastuzumab, Pegfilgrastim, Adalimumab, Bevacizumab

* **Novel Biologics:** Itolizumab

* **Small Molecules:** Rosuvastatin, Atorvastatin, Tacrolimus, Mycophenolate Mofetil

* **Branded Formulations:** A range of formulations in therapeutic areas like diabetology, oncology, and immunology.

Business Registration Information:

Manager:

Kiran Mazumdar-Shaw, Siddharth Mittal

Phone:

+91 80 2808 2808

E-mail:

corp.comm@biocon.com

Official Website:
Address:

Biocon House, Semicon Park, Sarjapur-Marthahalli Outer Ring Road, Doddathogur, Bengaluru 560 100, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.